FDA raises the bar for new diabetes drugs

WASHINGTON (AP) -- New drugs to treat an epidemic of diabetes will have to be screened more closely for heart risks, federal health officials said Wednesday. The Food and Drug Administration's policy change should offer a greater assurance of safety to doctors and patients. But it will make it more costly and time-consuming for companies to develop drugs that lower blood sugars. Well over 100 such medications are in some stage of development....

Read the whole article on AP Health

More from AP Health